NEWS & SCIENTIFIC UPDATES
Company announcements, scientific presentations, media and milestones from VCD Medical.
September 29, 2026 – Press Release
VCD Medical Receives U.S. FDA 510(k) Clearance for VEnice™ Vein Closure Device
Clearance includes percutaneous and surgical use in superficial and perforator veins.
July 2026 – Media
VCD Medical on VEnice™ and the Future of Venous Care
Francesco Piccagli, Denna Babul and Steve Elias, MD, discuss VCD Medical and the VEnice™ Vein Closure Device.
May 7, 2026 – Press Release
VCD Medical Appoints Denna Babul as General Manager, U.S.
Babul joined VCD Medical to lead U.S. market readiness.
VCD Science in Action
October 3, 2026 – The VEINS 2026
Interim 6-month Results of the BERG02 Study: A Core Lab-Adjudicated Study of Percutaneous Ligation of Superficial and Perforator Veins Combined With Sclerotherapy Using a Novel Device
Steve Elias, MD | Interim six-month BERG02 results from a core lab-adjudicated study.
April 30, 2026 – Venous Symposium 2026
Vein Closure Device (VCD): First in Human Trial Results and Next Steps
Steve Elias, MD | First-in-human clinical results and next steps for VCD Medical’s vein closure technology.
2025 – The VEINS–VIVA
Clinical Feasibility and Safety Study of the Use of a Novel Device for the Treatment of Chronic Venous Insufficiency of the Lower Limb
Steve Elias, MD | Clinical feasibility and safety findings evaluating the novel device in chronic venous insufficiency.
2024 – American Venous Forum
Quickshot: Preclinical Study to Evaluate a Novel Device for Selective Closure of Superficial Veins Through Percutaneous Access Under Ultrasound Guidance
Steve Elias, MD | Preclinical evaluation of selective superficial vein closure using percutaneous ultrasound-guided access.
2023 – UIP World Congress of Phlebology
VCD: Vein Closure Device
Edoardo Cervi, MD | Presentation of VCD’s percutaneous, ultrasound-guided approach to selective superficial vein
closure.
Awards & Recognitions
Best Startup of “Premio 2031” Platform
Startup Award
Best Startup of “Premio 2031” Platform
“Meet in Italy for Life Sciences”
2022 Special Awards
2022 Special Awards
Finalist AT I-Tech Innovation 2022
VCD Medical Patents
| Italy: | Percutaneous Device for Closing a Blood Vessel (IT102020000016426); Improved Percutaneous Device for Closing a Blood Vessel (IT102023000010176) |
| US: | Percutaneous Device for Closing a Blood Vessel (US11,931,044) |
| Japan: | Percutaneous Device for Closing a Blood Vessel (JP7644973) |
| EU: | Percutaneous Device for Closing a Blood Vessel (EP4197459) |
Stay connected with VCD Medical
For company news, scientific information or media inquiries, contact VCD Medical.